Summary:
- Xgene Pharmaceutical has developed a novel non-opioid multimodal analgesic that demonstrated significant pain reduction and reduced opioid consumption in a post-surgical pain trial.
- The multimodal analgesic, which combines multiple mechanisms of action, was able to provide effective pain relief without the side effects and addiction risks associated with opioid painkillers.
- The positive results from this clinical trial suggest the potential for this non-opioid pain medication to offer a safer and more effective alternative for managing post-surgical pain, addressing a critical need in the healthcare industry.